Sobi
A Senior Science and Technology Specialist at Sobi leads the manufacturing and analytical processes for small-molecule drug substances, ensuring compliance, reliability, and sustainability in clinical and commercial phases.
Headquarters
Stockholm, Stockholm, Sweden
Company Size
1001-5000 employees
Founded
2009
Sobi is a specialised international biopharmaceutical company focused on transforming the lives of people with rare diseases by developing and delivering innovative medicines. The company invests heavily in R&D and maintains a strong pipeline, with expanded patient access and commercialization as core priorities. Headquartered in Stockholm, Sobi operates globally and partners with healthcare providers, patient communities and other stakeholders to bring novel therapies to market. It also emphasizes sustainability, transparency and investor engagement as part of its long‑term strategy.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sobi.
42% above the average for this role
Director, CMC Drug Substance
Olema Oncology
Analytical Development Lead
Relay Therapeutics
Principal Scientist, Analytical Development – Drug Substance
MapLight Therapeutics
Vice President, Drug Substance
BioCryst Pharmaceuticals
Associate Director, Small Molecule Drug Substance MSAT
Servier
Senior Director, Drug Substance (Small Molecule)
Structure Therapeutics